226 related articles for article (PubMed ID: 27384720)
1. Delay in Diagnosis and Its Effect on Clinical Outcome in High-grade Sarcoma of Bone: A Referral Oncological Centre Study.
Goedhart LM; Gerbers JG; Ploegmakers JJ; Jutte PC
Orthop Surg; 2016 May; 8(2):122-8. PubMed ID: 27384720
[TBL] [Abstract][Full Text] [Related]
2. Delays in the health care system for children, adolescents, and young adults with bone tumors in Brazil.
Balmant NV; de Paula Silva N; de O Santos M; de S Reis R; de Camargo B
J Pediatr (Rio J); 2019; 95(6):744-751. PubMed ID: 30075119
[TBL] [Abstract][Full Text] [Related]
3. [Demographic Analysis of Patients with Osteosarcoma, Chonddrosarcoma, Ewing's Sarcoma from one Sarcoma Center in Switzerland].
Hodel S; Seeli F; Fuchs B
Praxis (Bern 1994); 2015 Jun; 104(13):673-80. PubMed ID: 26081379
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
5. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.
Widhe B; Widhe T
J Bone Joint Surg Am; 2000 May; 82(5):667-74. PubMed ID: 10819277
[TBL] [Abstract][Full Text] [Related]
6. Presenting symptoms and treatment delay in osteosarcoma and Ewing's sarcoma.
Sneppen O; Hansen LM
Acta Radiol Oncol; 1984; 23(2-3):159-62. PubMed ID: 6331085
[TBL] [Abstract][Full Text] [Related]
7. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
8. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
[TBL] [Abstract][Full Text] [Related]
9. Diagnoses, treatment, and oncologic outcomes in patients with calcaneal malignances: Case series, systematic literature review, and pooled cohort analysis.
Newman ET; van Rein EAJ; Theyskens N; Ferrone ML; Ready JE; Raskin KA; Lozano Calderon SA
J Surg Oncol; 2020 Dec; 122(8):1731-1746. PubMed ID: 32974945
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
11. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
12. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
[TBL] [Abstract][Full Text] [Related]
13. Bone Cancer: Diagnosis and Treatment Principles.
Ferguson JL; Turner SP
Am Fam Physician; 2018 Aug; 98(4):205-213. PubMed ID: 30215968
[TBL] [Abstract][Full Text] [Related]
14. Prognostic effects of doctor-associated diagnostic delays in osteosarcoma.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
Arch Orthop Trauma Surg; 2009 Oct; 129(10):1421-5. PubMed ID: 19280203
[TBL] [Abstract][Full Text] [Related]
15. Ewing sarcoma of the rib--initial symptoms and clinical features: tumor missed at the first visit in 21 of 26 patients.
Widhe B; Widhe T; Bauer HC
Acta Orthop; 2007 Dec; 78(6):840-4. PubMed ID: 18236193
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy.
Aran V; Devalle S; Meohas W; Heringer M; Cunha Caruso A; Pinheiro Aguiar D; Leite Duarte ME; Moura Neto V
Crit Rev Oncol Hematol; 2021 Jun; 162():103340. PubMed ID: 33894338
[TBL] [Abstract][Full Text] [Related]
17. Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades.
Chen I; Pasalic D; Fischer-Valuck B; Frangoul H; DeWees T; Shinohara ET; Perkins SM
Am J Clin Oncol; 2018 May; 41(5):471-475. PubMed ID: 27841802
[TBL] [Abstract][Full Text] [Related]
18. Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience.
Zaikova O; Sundby Hall K; Styring E; Eriksson M; Trovik CS; Bergh P; Bjerkehagen B; Skorpil M; Weedon-Fekjaer H; Bauer HC
J Surg Oncol; 2015 Dec; 112(8):853-60. PubMed ID: 26482729
[TBL] [Abstract][Full Text] [Related]
19. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
20. Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.
Lawrenz JM; Styron JF; Parry M; Grimer RJ; Mesko NW
Bone Joint J; 2018 May; 100-B(5):652-661. PubMed ID: 29701086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
